LHNVD

[Matthew Perrone @AP_FDAwriter]

One of the largest medical device recalls in history is set to drag into next year, stoking anger from CPAP users and leading @US_FDA officials to weigh unprecedented legal action: https://t.co/5IlhfyXZE4

[LHNVD @LHNVD]

In 2018, an estimated 5.7 million men, 3.2 million women and 1.1 million children were impacted by #TB around the world. There were cases in all countries and age groups. But TB is curable and preventable. #ItsTimeToEndTB #WorldTBDay

[Dr. Jono Mermin @DrMerminCDC]

Today is #WorldTBDay! Despite Robert Koch’s discovery of the Mycobacterium #tuberculosis over 130 years ago, TB is still a leading cause of death worldwide. Learn more about the disease and what #CDC is doing about it: https://t.co/5f7fbgfqz3

[LHNVD @LHNVD]

Approximately 1/4 of the world's population has latent #tuberculosis. Testing and treating latent #TB infection is the most effective way to prevent TB. #ItsTimeToEndTB #WorldTBDay

[LHNVD @LHNVD]

Jeff Fischer, President of @LHNVD discusses the sample collection tool shortages faced by the US healthcare system and how the company is ramping production with @GenomeWeb . Read full article here - https://t.co/AdnKpNnHa2

[LHNVD @LHNVD]

According to @WHO, a total of 1.5 million people died from #TB in 2018. TB is one of the top 10 causes of death worldwide and the leading cause from a single infectious agent. #WorldTBDay #ItsTimeToEndTB

[LHNVD @LHNVD]

@US_FDA encouraged @LHNVD to collaborate with diagnostic assay manufacturers to ensure that @PrimeStoreMTM is included as a transport device in Emergency Use Authorization applications for research samples for #COVID19. Read full release here - https://t.co/uMiXOf5hkS

[LHNVD @LHNVD]

As Worries Grow Over Novel Coronavirus, Dx Industry Jumps Into Action https://t.co/RH8TCkIXiR

[LHNVD @LHNVD]

Clinical Investigators Validating Mouth Swab PCR Test for TB https://t.co/pMxwgf6eOg

[LHNVD @LHNVD]

Jeff Fisher, CEO of Longhorn discusses the key role of diagnostic tests in detecting and treating diseases to improve global health in @PharmaVOICE. Read more here - https://t.co/nTsc3Qz76k

[LHNVD @LHNVD]

“Diseases that are detected early, especially before symptoms occur, are often easier to treat, require fewer interventions, and use significantly less resources” noted Jeff Fischer, CEO of Longhorn in #latestissue of @PharmaVOICE that highlights the importance of #earlydetection

[Luke T. Daum, Ph.D. 🇺🇸 @lukedaum]

Great poster presentation today by Dr. Nimisha Rikhi at the #TBScience @TheUnion_TBLH describing monoclonal antibodies generated from Mycobacterium tuberculosis. Very proud to have her part of Team Longhorn Vaccines & Diagnostics (Union booth D3304). @LHNVD

[LHNVD @LHNVD]

Dr. Daum discusses why some strains of Mycobacterium tuberculosis are preferentially associated with multiple drug resistances at @UnionConference

[LHNVD @LHNVD]

Longhorn is thrilled to present oral abstract titled ���Targeted Next-Generation Sequencing Methodology for Characterizing High-Prevalence Multi-Drug Resistance Mycobacterium tuberculosis Mutations” at @UnionConference . https://t.co/UkENWmH8uz

[LHNVD @LHNVD]

According @WHO an estimated 2.74 million Indians suffer from #tuberculosis. Early diagnosis is the most efficient way to end this epidemic. Join Longhorn at @UnionConference and click here to read full announcement: https://t.co/UkENWmH8uz

[LHNVD @LHNVD]

Longhorn Vaccines & Diagnostics to present scientific data at The 50th Union World Conference on Lung Health on November 1. Click here to read full announcement: https://t.co/UkENWmH8uz
#tuberculosis #lunghealth #UnionConf

[LHNVD @LHNVD]

Longhorn is proud to present an oral abstract at @UnionConference on November 1 and join other researchers and companies in the fight against #Tuberculosis #UnionConf. Read the full announcement here: https://t.co/UkENWmH8uz